[ad_1]
“If successfully developed and approved, an mRNA-based Malaria vaccine could be produced here (Africa),” said Türeci. said.
In addition to Kovid-19 and malaria, BioNTech aims to produce mRNA-based tuberculosis vaccines that it has developed and will be tested on humans in Africa.
On the other hand, according to the World Malaria Report published by the World Health Organization (WHO) on December 8, it was estimated that around 619 thousand people died from malaria in 2021 worldwide.
[ad_2]
Source link
